18th Colombian Congress of Hemodynamics and Cardiovascular Interventionism to Start This Week

On November 9 thru 11, 2023, the 18th Colombian Congress of Hemodynamics and Cardiovascular Interventionism will be held at the Blue Garden Convention Center (6th floor) in Barranquilla. 

The event will feature important Latin American and International key note speakers and is oriented to interventional cardiologists and to all healthcare professionals involved in the treatment of cardiovascular disease, which continues to be the main cause of morbimortality globally.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Save the Date! CardioInterv 2025 – 25th International Symposium on Interventional Cardiology is Coming

From November 26 to 28, 2025, the 25th International Symposium on Interventional Cardiology – CardioInterv 2025 will take place, a scientific excellence event that...

Invitation of the MIL Group to RISE at the ESC 2024 Congress

The Group of Latin American Interventional Women invites you to participate in the next RISE, a professional development conference for women in cardiology promoted...

Artificial Intelligence in Complex PCI Cases – 2nd International Symposium of Cardiology

The Latin American Society of Interventional Cardiology invites the whole community to take part in the 2nd International Symposium of Cardiology entitled “Artificial Intelligence...

SOLACI@PCR Joint Session at EuroPCR 2024 – See You in Paris on May 14 thru 17

The Latin American Society of Interventional Cardiology will once more say here at EuroPCR 2024, undoubtedly one of the most relevant international meetings in...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2026 | CHIP-BCIS3: Impella use as support in high-risk complex PCI

The use of percutaneous ventricular support during high-risk complex PCI has been proposed as a strategy to prevent hemodynamic deterioration in patients with severe...

ACC 2026 | ORBITA-CTO: PCI in chronic total occlusions and stable angina — the randomized trial we were missing?

Percutaneous coronary intervention (PCI) for chronic total occlusions (CTO) remains a topic of ongoing debate in stable angina, with persistent uncertainty regarding its role...

ACC 2026 | FAST III: vFFR vs FFR in physiology-guided revascularization of intermediate coronary lesions

Physiological assessment of intermediate coronary lesions remains a cornerstone in decision-making for coronary revascularization. Although FFR continues to be one of the guideline-recommended references,...